Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways

Rahib, 2014, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res., 74, 2913, 10.1158/0008-5472.CAN-14-0155

Neoptolemos, 2004, A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer, N. Engl. J. Med., 350, 1200, 10.1056/NEJMoa032295

Abbruzzese, 2014, New option for the initial management of metastatic pancreatic cancer?, J. Clin. Oncol., 32, 2405, 10.1200/JCO.2013.54.4155

Rhim, 2012, EMT and dissemination precede pancreatic tumor formation, Cell, 148, 349, 10.1016/j.cell.2011.11.025

Islam, 2015, Cancer stem cell: fundamental experimental pathological concepts and updates, Exp. Mol. Pathol., 98, 184, 10.1016/j.yexmp.2015.02.002

Abdullah, 2013, Mechanisms of chemoresistance in cancer stem cells, Clin. Transl. Med., 2, 3, 10.1186/2001-1326-2-3

Dalla Pozza, 2015, Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bidirectionally convert into cancer stem cells, Int. J. Oncol., 46, 1099, 10.3892/ijo.2014.2796

Cecconi, 2011, Proteomics of human cancer tissues and cells, TrAC Trends Anal. Chem., 30, 346, 10.1016/j.trac.2010.10.016

Brandi, 2016, Secretome protein signature of human pancreatic cancer stem-like cells, J. Proteome, 136, 1, 10.1016/j.jprot.2016.01.017

Shilov, 2007, The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra, Mol. Cell. Proteomics, 6, 1638, 10.1074/mcp.T600050-MCP200

Tang, 2008, Nonlinear fitting method for determining local false discovery rates from decoy database searches, J. Proteome Res., 7, 3661, 10.1021/pr070492f

D'Alessandro, 2011, A robust high resolution reversed-phase HPLC strategy to investigate various metabolic species in different biological models, Mol. BioSyst., 7, 1024, 10.1039/c0mb00274g

Sana, 2008, A sample extraction and chromatographic strategy for increasing LC/MS detection coverage of the erythrocyte metabolome, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 871, 314, 10.1016/j.jchromb.2008.04.030

Bian, 2015, Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer, Biochem. Biophys. Res. Commun., 463, 612, 10.1016/j.bbrc.2015.05.108

Prigione, 2014, HIF1alpha modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2, Stem Cells, 32, 364, 10.1002/stem.1552

Cheng, 2013, How does hypoxia inducible factor-1alpha participate in enhancing the glycolysis activity in cervical cancer?, Ann. Diagn. Pathol., 17, 305, 10.1016/j.anndiagpath.2012.12.002

Zhao, 2014, Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin, Cancer Res., 74, 2455, 10.1158/0008-5472.CAN-13-3009

Sancho, 2016, Hallmarks of cancer stem cell metabolism, Br. J. Cancer, 10.1038/bjc.2016.152

Luo, 2015, Metabolic plasticity of cancer stem cells, Oncotarget, 6, 35141, 10.18632/oncotarget.6177

Dong, 2013, Loss of FBP1 by snail-mediated repression provides metabolic advantages in basal-like breast cancer, Cancer Cell, 23, 316, 10.1016/j.ccr.2013.01.022

Shen, 2015, Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma, Cell Cycle, 14, 86, 10.4161/15384101.2014.974419

D'Alessandro, 2014, Metabolic effect of TAp63alpha: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defense, Oncotarget, 5, 7722, 10.18632/oncotarget.2300

Gevi, 2012, Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM, J. Proteome, 76, 10.1016/j.jprot.2012.03.012

Schulze, 2012, How cancer metabolism is tuned for proliferation and vulnerable to disruption, Nature, 491, 364, 10.1038/nature11706

Son, 2013, Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway, Nature, 496, 101, 10.1038/nature12040

Moore, 2001, Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4, Virchows Arch., 439, 798, 10.1007/s004280100474

Fan, 2014, Quantitative flux analysis reveals folate-dependent NADPH production, Nature, 510, 298, 10.1038/nature13236

Chen, 2013, Functions of heterogeneous nuclear ribonucleoproteins in stem cell potency and differentiation, Biomed. Res. Int., 2013, 623978

Hassa, 2009, The molecular "Jekyll and Hyde" duality of PARP1 in cell death and cell survival, Front. Biosci., 14, 72, 10.2741/3232

Lee, 2016, Long-duration three-dimensional spheroid culture promotes Angiogenic activities of adipose-derived Mesenchymal stem cells, Biomol. Ther., 24, 260, 10.4062/biomolther.2015.146

Kim, 2008, DNA repair Ku proteins in gastric cancer cells and pancreatic acinar cells, Amino Acids, 34, 195, 10.1007/s00726-006-0411-1

Puebla-Osorio, 2014, A novel Ku70 function in colorectal homeostasis separate from nonhomologous end joining, Oncogene, 33, 2748, 10.1038/onc.2013.234

Jiang, 2014, Up-regulated FASN expression promotes transcoelomic metastasis of ovarian cancer cell through epithelial-mesenchymal transition, Int. J. Mol. Sci., 15, 11539, 10.3390/ijms150711539

Li, 2014, Fatty acid synthase mediates the epithelial-mesenchymal transition of breast cancer cells, Int. J. Biol. Sci., 10, 171, 10.7150/ijbs.7357

Zaytseva, 2012, Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer, Cancer Res., 72, 1504, 10.1158/0008-5472.CAN-11-4057

Mullen, 2015, Progress in the development of fatty acid synthase inhibitors as anticancer targets, Bioorg. Med. Chem. Lett., 25, 4363, 10.1016/j.bmcl.2015.08.087

Jiang, 2014, In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells, Br. J. Cancer, 111, 1562, 10.1038/bjc.2014.431

Warita, 2014, Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion, Sci. Rep., 4, 7593, 10.1038/srep07593